Attach to Form 990 or Form 990-EZ.
See separate instructions.| (i) Name of supported organization |
(ii) EIN |
(iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) |
(iv) Is the organization in col. (i) listed in your governing document? |
(v) Did you notify the organization in col. (i) of your support? |
(vi) Is the organization in col. (i) organized in the U.S.? |
(vii) Amount of support? |
|||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | ||||
| Total | |||||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3.. | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public Support. Subtract line 5 from line 4. | ||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. | ||||||
| 11 | Total support (Add lines 7 through 10). | ||||||






| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public Support (Subtract line 7c from line 6.) | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) | ||||||
| 13 | Total support (Add lines 9, 10c, 11 and 12.). | ||||||




| Facts And Circumstances Test |
|---|
| Explanation |
|---|
| Pursuant to the Internal Revenue Service Ruling Letter dated November 5, 1998, the Institute is a medical research organization for the taxable year ended August 31, 2010. As a medical research organization, HHMI's expenditures on a cash basis of $795,087,404 exceed the MRO requirement (3.5% of HHMI endowment) of $529,715,317. |
| List of hospital affiliations for e-filing: Hospital,City,State,Zip Code/ B&W Hospital,Boston,MA,02115/ Children's Hosp,Boston,MA,02115/ Children's Hosp,Cincinnati,OH,45229/ Dana-Farber,Boston,MA,02115/ Fred Hutch,Seattle,WA,98109/ JHopkins Hosp,Baltimore,MD,21205/ Mass Gen Hosp,Boston,MA,02129/ MSKCC,New York,NY,10021/ Nat'l Jewish,Denver,CO,80206/ St. Jude,Memphis,TN,38105/ Duke-Duke Hosp,Durham,NC,27706/ Emory-Univ Hosp,Atlanta,GA,30322/ NYU-NYU Hosps,New York,NY,10016/ OHSU-OHSU Hosp,Portland,OR,97239/ Rockefeller-Hosp,New York,NY,10021/ Stanford-Hosp,Palo Alto,CA,94305/ UCLA-Med Ctr,Los Angeles,CA,90095/ UCSD-Med Ctr,San Diego,CA,92093/ UCSF-UCSF Hosps,San Francisco,CA,94143/ UIowa-UIowa Hosps,Iowa City,IA,52242/ UMass-Med Ctr,Worcester,MA,01605/ UMich-UMich Hosp,Ann Arbor,MI,48109/ UPenn-UPenn Hosp,Philadelphia,PA,19104/ UT-Austin-UT Hosp,Austin,TX,78712/ UTSW-UTSW Hosps,Dallas,TX,75390/ UUtah-UUtah Hosps,Salt Lake City,UT,84112/ UWash-Med Ctr,Seattle,WA,98195/ Vanderbilt-Hosp,Nashville,TN,37232/ ADARC-aff hosp,New York,NY,10016/ AECOM-affil hosps,New York,NY,10461/ Baylor-aff hosps,Houston,TX,77030/ BU-aff hosp,Boston,MA,02126/ Brandeis-aff hsps,Waltham,MA,02254/ CalTech-aff hosps,Pasadena,CA,91125/ Carnegie-aff hsps,Baltimore,MD,21210/ Case WR-aff hosps,Cleveland,OH,44106/ CSHL-affil hosps,Cold Spring Harbor,NY,11724/ CSU-affil hosp,Fort Collins,CO,80521/ Columbia-aff hsps,New York,NY,10027/ Cornell-aff hosps,New York,NY,14853/ Harvard-aff hosps,Cambridge,MA,02138/ TJL-affil hosps,Bar Harbor,ME,04609/ JHU-affil hosps,Baltimore,MD,21218/ MIT-affil hosps,Boston,MA,02139/ NWU-affil hosps,Evanston,IL,60208/ OMRF-aff hosp,Oklahoma City,OK,73104/ Princeton-aff hosps,Princeton,NJ,08544/ Purdue-aff hosp,W. Lafayette,IN,47907/ Rutgers-affil hosp,Piscataway,NJ,08854/ Salk-affil hosps,La Jolla,CA,92093/ Stowers-aff hosps,Kansas City,MO,64110/ SUNY-affil hosps,Stony Brook,NY,11794/ Texas A&M-aff hsp,College Station,TX,77843/ Tufts-aff hosps,Boston,MA,02111/ UAZ-affil hosp,Tucson,AZ,85721/ UCB-affil hosps,Berkeley,CA,94720/ UC-Davis-affil hsps,Davis,CA,95616/ UCSC-aff hosps,Santa Cruz,CA,95064/ UChi-affil hosp,Chicago,IL,60637/ UColo-aff hosp,Boulder,CO,80309/ UColo-aff hosp,Denver,CO,80217/ UFla-aff hosps,Gainesville,FL,32611/ UIllinois-aff hsp,Urbana,IL,61801/ UMD-affil hosp,Baltimore,MD,21201/ UMDNJ-aff hosp,Piscataway,NJ,08544/ UNC-affil hosps,Chapel Hill,NC,27599/ UOregon-aff hsp,Eugene,OR,97403/ UWisc-affil hosps,Madison,WI,53706/ WashU-aff hosp,St.Louis,MO,63130/ YaleU-affil hosp,New Haven,CT,06520/ |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.| Identifier | Return Reference | Explanation |
|---|---|---|
| Authority over Financial Account in a Foreign Country | Core Form, Part V, Line 4b | RUSSIA ARGENTINA AUSTRALIA AUSTRIA BELGIUM BERMUDA BRAZIL CANADA CHILE CHINA COLOMBIA CZECH REPUBLIC DENMARK EGYPT ESTONIA FINLAND FRANCE GERMANY GREECE HONG KONG HUNGARY INDIA INDONESIA IRELAND ISRAEL ITALY JAPAN JORDAN LUXEMBOURG MALAYSIA MAURITIUS MEXICO MOROCCO NETHERLANDS NEW ZEALAND NORWAY PERU PHILIPPINES POLAND PORTUGAL SINGAPORE SLOVENIA SOUTH AFRICA SOUTH KOREA SPAIN SRI LANKA SWEDEN SWITZERLAND TAIWAN THAILAND TURKEY UKRAINE UNITED KINGDOM URUGUAY VENEZUELA ZIMBABWE HHMI has signature authority over investment accounts in foreign countries through their custodian, Bank of New York Mellon. HHMI also has direct signature authority in Mauritius and Singapore. |
| Relationships Between Trustees/officers | Core Form, Part VI, Line 2 | HHMI Trustee Dr. Joseph Goldstein is also a Trustee of the Rockefeller University, which was the employer of HHMI Trustee Dr. Paul Nurse during part of HHMI's 2011 fiscal year. Dr. Nurse is no longer an employee of Rockefeller University. Both HHMI Trustee Anne Tatlock and former HHMI President Dr. Thomas Cech served as directors of Merck & Co., Inc., during HHMI's 2011 fiscal year. |
| Description of 990 Review Process | Core Form, Part VI, Line 11A | The Howard Hughes Medical Institute's Form 990 is initially prepared by its Tax Compliance Department, in coordination with other HHMI departments as needed. The draft return is reviewed by senior management of HHMI's Finance Department and by attorneys in HHMI's Office of the General Counsel. Following these reviews and the resolution of any questions that have been raised, the draft return is reviewed by HHMI's outside tax preparer. Finally, a copy of the return is provided to the members of HHMI's Board of Trustees so that they have an opportunity to review and comment on the return before it is filed. |
| Conflict of Interest Policy | Core Form, Part VI, Line 12a-12c | In addition to HHMI's code of conduct, which addresses conflicts of interest and applies to all HHMI employees, officers, Trustees, and advisors, HHMI has specific conflict of interest policies for different categories of personnel. Under the HHMI policies that apply to Trustees, officers, and key employees, these individuals must disclose annually interests that could give rise to conflicts of interest, and must certify annually their compliance with the conflict of interest policy that applies to them. Annual disclosures and certifications are reviewed by HHMI's Office of the General Counsel, and by other HHMI managers as needed. The conflict of interest policy covering HHMI's Trustees also requires each Trustee to disclose to the other Trustees any actual or apparent conflict of interest with respect to a proposed HHMI transaction. If the other Trustees decide that there is only the appearance of a conflict of interest, and that it could not reasonably be considered to affect the independent, unbiased judgment of the disclosing Trustee with respect to the transaction at issue, no further action is required to address the apparent conflict. In all other cases, including all actual conflicts of interest, the disclosing Trustee is not permitted to participate in the deliberation or decision regarding the transaction under consideration, and must leave the room during the deliberation and vote. The conflict of interest policy covering HHMI's officers and key employees requires each covered individual to obtain supervisory approval up to the level of HHMI's President before entering into an affiliation with or acquiring an interest of 1% or more in any entity that is or may become a recipient of HHMI funds. HHMI's President, in consultation with HHMI's General Counsel, may permit the affiliation or interest if it would not interfere with the covered individual's performance of his or her HHMI responsibilities, would not create the appearance of a conflict of interest, and would be consistent with sound business judgment. HHMI's President may set conditions on approval, for example that there be no remuneration to the covered individual. Proposed affiliations and interests of 1% or more of HHMI's President are subject to the approval of the Chairman of the Trustees. |
| Process for determining compensation | Core Form, Part VI, Lines 15a-b | The compensation for HHMI's President, other officers, and key employees is set using the following procedures. Every other year, the Audit and Compensation Committee of HHMI's Board of Trustees engages one or more independent compensation consultants to conduct a study of comparable market data. The study includes data for HHMI's President, other officers, and key employees. The independent compensation consultants also provide an opinion regarding the reasonableness of the compensation arrangements for the positions included in the study. The study includes comparable market data for all components of compensation for each person covered by the study, including base salary, incentive compensation (if any), and benefits. The Committee relies on the market data and opinion provided by the compensation consultant in making recommendations to the Board of Trustees regarding compensation for HHMI's President, other officers and key employees. The decision is made by independent Trustees. Any Trustee who has a conflict of interest with respect to a specific officer or key employee must recuse himself or herself from the decision on that person's compensation, and leave the meeting room during the debate and voting on it. In the alternate years when a study is not done, the Audit and Compensation Committee confirms with the independent compensation consultants that the range of any proposed merit increases for HHMI employees, including senior management, is reasonable compared with generally prevailing compensation increases in the market over the past year. The Committee relies on this advice in recommending compensation for HHMI's President, other officers and key employees, and the Board of Trustees relies on this advice in making compensation decisions. Recusal procedures are the same in as in the years when a study is done. In each year, minutes of the discussions and decisions regarding compensation are prepared after each meeting and are submitted for approval at the next meeting. Approved minutes are kept in HHMI's records. All minutes include the date of the meeting, identify those Trustees who attended and voted on the compensation arrangements, and note any recusals of Trustees with a conflict of interest. The comparability studies and opinions relied on at the meeting are referenced in the minutes, and copies of these materials are also kept in HHMI's records. HHMI's Board of Trustees followed this process in August 2011 in determining compensation for the following positions: President; Vice Presidents; and Managing Directors - Investments. |
| Governing documents etc available to the public | Core Form, Part VI, Line 19 | HHMI's practice has been to make a copy of its charter and by-laws available on request. HHMI's code of conduct, which addresses conflicts of interest, is available to the public on the HHMI web site. A downloadable copy of HHMI's most recent audited financial statements is also available to the public on the web site. In addition, HHMI publishes an annual report that provides a summary of each year's activity, expenditures, and financial performance; this publication is widely distributed in print and is posted on the HHMI web site. |
| Whistleblower policy | Core Form, Part VI, Line 13 | HHMI has had a written whistleblower policy in place since 2003. While this policy has been discussed with HHMI's Trustees in the past, it was not formally adopted by the Trustees or a committee of the Trustees before the end of the tax year covered by this Form 990. The policy is expected to be presented to the Trustees or a committee of the Trustees for approval in the tax year covered by HHMI's next Form 990. |
| Document Retention & Destruction Policy | Core Form, Part VI, Line 14 | HHMI has had written document retention and destruction policies in place for many years. These policies were not adopted by HHMI's Trustees or a committee of the Trustees before the end of the tax year covered by this Form 990. The policies are expected to presented to the Trustees or a committee of the Trustees for approval in the tax year covered by HHMI's next Form 990. |
| Other Changes of Net Assets | Core Form, Part XI, Line 5 | Unrealized gains on investments |
| Attachment 2 (continued-1) | Part III, Program Service, line 4a - Medical Research | (H) Highlights from HHMI Research Laboratories (Fiscal Year 2011) (1) The Tangled Biology of Aggression David Anderson, California Institute of Technology You can be a lover or a fighter-but not at the same time, and studies in mice are hinting at why. Examining the activity of neurons in a tiny region buried deep within the animals' brains, researchers found that the neural circuits controlling aggression and mating are closely intertwined. Specifically, postdoctoral researcher Dayu Lin in Anderson's lab recorded the activity of individual neurons in the ventromedial nucleus of the hypothalamus. He found that one subset of neurons fired during aggressive behavior, and a partially overlapping but distinct set fired during mating. Many of the aggression neurons were inhibited during mating. However, when the researchers overcame this inhibition in male mice by artificially stimulating the neurons associated with aggression, the mice attacked females rather than mating with them. The close relationship between the two groups of neurons may normally help suppress aggressive behavior during mating. (2) Antibiotic Resistance: A Team Effort James Collins, Boston University With teamwork, entire groups of bacteria can resist certain antibiotics, even when only a few individuals have their own tools for survival. Researchers discovered this bacterial altruism when they grew E. coli in the presence of the antibiotic norfloxacin and removed small samples to test for acquired resistance to the drug. They discovered that under the onslaught of norfloxacin, a few of the bacteria acquired resistance and manufactured a metabolite called indole, which seeped into the communal broth and triggered protective mechanisms in their nonresistant neighbors. The researchers say that drugs designed to interfere with the indole pathway might block the microbes' ability to share resistance. (3) Shutting Off Anxiety Karl Deisseroth, Stanford University Scientists are beginning to shine a light on the neural circuits that underlie anxiety, the most common psychiatric disease. With the flick of a light-activated genetic switch that lets them manipulate specific neurons in the brain, scientists have reduced symptoms of anxiety in laboratory mice. The experiments demonstrated that a cluster of neurons in the amygdala-an almond-shaped structure in the brain-helps control apprehension in the absence of any immediate threat. By manipulating the activity of two distinct neural circuits, which they found to have opposing effects on anxiety, the researchers could elicit strikingly rapid effects on anxiety-related behaviors in mice. (4) Preventing Aortic Aneurysm in Marfan Patients Harry Dietz, The Johns Hopkins University School of Medicine Losartan, an FDA-approved drug used to treat high blood pressure, is being evaluated for its ability to prevent enlargement of the aorta in patients with Marfan syndrome. The clinical trials follow promising experiments in which losartan dramatically slowed aneurysm progression in a mouse model of Marfan syndrome. While the trials are under way, researchers continue to investigate the cellular signals that contribute to aneurysm progression in Marfan syndrome. Their experiments have generated a new understanding of those signals-and how losartan alters them-that is expected to help guide both current treatment decisions and efforts to develop therapies that might offer benefits that losartan does not. (5) Spotting Cancer Stem Cells in the Crowd Elaine Fuchs, The Rockefeller University Stem cells can differentiate into multiple cell types and divide in perpetuity, two qualities that make them potential tools for regenerative medicine. Cancer stem cells, on the other hand, use the same characteristics to wreak havoc. Two signaling pathways that scientists found are critical to regulating the growth of squamous cancer stem cells-which can seed tumors in the skin, head, neck, lungs, esophagus, and other tissues-will now help researchers discriminate between those menacing cells and normal stem cells in the skin. Interfering with these cancer-specific pathways could lead to drugs that destroy cancer stem cells more effectively while sparing normal stem cells. (6) Antibody Recognizes Many Strains of Flu Stephen Harrison, Harvard Medical School Strains of influenza virus change so much that a new vaccine must be developed every year to prime patients' immune systems to target the current threat. After studying a patient with an unusually well-equipped immune system, researchers think it may be possible to ready the body to fight off a wide variety of influenza strains. From that individual's army of immune cells, scientists identified a single antibody that recognized and blocked 30 of 36 strains of influenza that have arisen since 1988. The antibody binds so tightly to a surface pocket on the virus that recognizes human cells that its binding appears not to be strongly affected if the surrounding area mutates. The researchers hope to use this information to design an influenza vaccine that provides broad protection against many strains of influenza. (7) Gene Editing Reduces Hemophilia Symptoms in Mice Katherine High, The Children's Hospital of Philadelphia The blood clotting disorder hemophilia B is caused by defects in a clotting factor called Factor IX. Researchers have corrected the disorder in mice by repairing the gene with a scissor-like molecular tool that snips out the defective region of the gene. The tool, called a zinc-finger nuclease, specifically targets the defective segment of DNA and is administered along with a flawless segment of the Factor IX gene. Once the defective segment is excised, the cell's DNA repair proteins take over, copying the correct version of the gene. After treatment with Factor IX zinc-finger nucleases, mice with severe hemophilia B gained enough clotting factors to downgrade their disease from severe to mild. (8) Missing DNA Key to Human Evolution David Kingsley, Stanford University School of Medicine Among the features that set humans apart from other animals are 510 segments of regulatory DNA that are present in other species but surprisingly missing from the human genome. Researchers showed that two of the missing sequences help explain why humans lack the sensory whiskers and spiny penises possessed by many other mammals, but have evolved much larger brains. The loss of specific regulatory sequences likely contributed to the evolution of these and other human traits. The findings mirror evidence from other species indicating that changes to regulatory regions of DNA, rather than to genes themselves, underlie many of the features that organisms acquire during evolution. (9) Spliceosome Caught on Camera Melissa Moore, University of Massachusetts Medical School Spliceosomes prepare the genetic code to be translated into proteins by chopping out long strings of genetic material and stitching the remaining segments back together. The spliceosome has five major parts that dynamically interact with one another and with the RNA that they process. In human cells, these components must find one another and assemble into a spliceosome millions of times a day to keep protein production moving along. By labeling each component with a different fluorescent tag and tracking the individual molecules with a microscope equipped with four different-colored lasers, researchers have now captured the massive spliceosome assembly on camera. They witnessed a continuous shifting of parts, which suggests that the assembly process can be shut down or reversed once it has begun. |
| Attachment 2 (continued-2) | Part III, Program Service, line 4a - Medical Research | (10) Searching for a Marker for PTSD Kerry Ressler, Emory University School of Medicine A single terrifying event can cause deep and lasting damage in some people, while leaving others psychologically unharmed. Now, researchers have discovered that a protein called PACAP (pituitary adenylate cyclase activating polypeptide) is present in higher levels in the blood of women with post-traumatic stress disorder than in those who experienced traumatic events but had not been diagnosed with the disorder. Experiments with mice suggest that PACAP activity in regions of the brain that mediate fear and stress increases in the presence of estrogen. The researchers say the results could lead to a blood test for susceptibility to PTSD in women. PACAP levels were not associated with PTSD symptoms in men. (11) Lighting Up the Fruit Fly Brain Julie Simpson, Janelia Farm Research Campus With a genetically encoded color palette, Janelia Farm scientists have transformed the neurons of a fruit fly's brain into disorderly rainbows of color. The new tool, called dBrainbow, gives different types of neurons distinct colors so scientists can trace their paths through the brain. dBrainbow expands the reach of the Brainbow technique developed by other researchers in 2007 for color coding the brains of mice. The new version will aid the studies of neuroscientists who investigate the brain of the fruit fly, a powerful system for learning about the neural basis of behavior. (12) The Origins of Two Epidemics Matthew Waldor, Brigham and Women's Hospital With the latest DNA sequencing technology, researchers have been hot on the trail of the pathogenic microbes responsible for two major outbreaks of infectious disease. In December 2010, they traced the origins of the strain of cholera responsible for the outbreak that began in Haiti in October 2010, killing more than 6,200 people. By comparing the genome sequence of bacteria isolated from patients affected during the post-earthquake outbreak with the sequences of cholera strains isolated in other parts of the world, the scientists concluded that the Haiti strain originated in South Asia. In May 2011, the scientists turned their attention to an unusual strain of E. coli that was sickening people in Germany-and would eventually cause symptoms in more than 4,000 people in 16 countries, including many cases of life-threatening hemolytic-uremic syndrome. They used a similar analysis to determine that the dangerous strain likely emerged when a less pathogenic E. coli picked up a critical set of virulence genes. (13) What It Takes to Control HIV Naturally Bruce Walker, Massachusetts General Hospital A small fraction of people who are infected with HIV can control it without drugs; they are now helping scientists learn about potential ways to fight the virus. The first genome-wide association study of these individuals, called elite controllers, has identified a few amino acids that seem to predict a person's ability to keep the virus in check. Those amino acids help determine how the immune system recognizes HIV-infected cells. The findings indicate what an effective natural immune response is and how it is induced-information that could help generate more effective vaccine-induced immune responses to prevent or treat HIV. (14) New Targets for Melanoma Therapies Leonard Zon, Children's Hospital Boston Researchers are using a tiny, translucent fish to identify cellular signals that can drive the development and progression of melanoma. After analyzing more than 2,100 zebrafish tumors, researchers identified a single enzyme, SETDB1, which seemed to accelerate melanoma. They followed these experiments with an analysis of human melanoma cell lines and found that the SETDB1 gene was overactive in 70 percent of those cells. Zebrafish also led researchers to a second molecule, DHODH, which is involved in formation of the stem cells that give rise to melanoma. This protein, which helps convert DNA to RNA, can be shut down with an arthritis drug, suggesting that the drug might be combined with existing therapies to treat melanoma in humans. (I) Honors and Awards Received by HHMI Scientists (1)Friedman Wins Lasker Award HHMI investigator Jeffrey M. Friedman of The Rockefeller University and Douglas Coleman of The Jackson Laboratory, won the 2010 Lasker Award for Basic Medical Research, the nation's most prestigious award in basic and clinical research. (2) Fuchs Wins Albany Medical Center Prize Elaine Fuchs, an HHMI investigator at Rockefeller University, was one of three scientists awarded the 2011 Albany Medical Center Prize in Medicine and Biomedical Research. (3) Wiley Prize Goes to Lily Y. Jan and Yuh Nung Jan HHMI investigators Lily Y. Jan and Yuh Nung Jan, a husband and wife team who share a lab at the University of California, San Francisco, won the 2011 Wiley Prize in Biomedical Sciences. (4) Lindquist and Benkovic Presented With National Medals of Science At a ceremony at the White House, President Obama presented a 2010 National Medal of Science to HHMI investigator Susan Lindquist of the Massachusetts Institute of Technology. Stephen J. Benkovic of Pennsylvania State University, who is a member of HHMI's Scientific Review Board, also received a medal. The National Medal is the nation's highest scientific honor given by the government. (5) Shaw Prize Given to Medzhitov The Shaw Prize Foundation awarded Ruslan M. Medzhitov, an HHMI investigator at Yale University, the Shaw Prize in Life Science and Medicine. (6) HHMI Scientists Join National Academy of Sciences Six HHMI investigators, one international research scholar, and one member of HHMI's Scientific Review Board were elected to the National Academy of Sciences. The investigators are David P. Bartel, Massachusetts Institute of Technology; Harry C. Dietz, The Johns Hopkins University School of Medicine; Steven E. Jacobsen, University of California, Los Angeles; David M. Kingsley, Stanford University School of Medicine; J. Andrew McCammon, University of California, San Diego; and Michel C. Nussenzweig, The Rockefeller University. The international research scholar is Alberto R. Kornblihtt, University of Buenos Aires. The HHMI Scientific Review Board member is Luis F. Parada, University of Texas Southwestern Medical Center at Dallas. (7) Six HHMI Researchers Elected to Institute of Medicine Elected this year to the National Academy of Sciences' Institute of Medicine were HHMI investigators Peter Cresswell, Yale University School of Medicine; Robert B. Darnell, The Rockefeller University; Jennifer A. Doudna, University of California, Berkeley; and Kevan M. Shokat, University of California, San Francisco. Also elected was HHMI early career scientist Karl Deisseroth, Stanford University. Sydney Brenner, a senior fellow at HHMI's Janelia Farm Research Campus, was named a foreign associate of the institute. (8) Chory and Steitz Elected to Royal Society HHMI investigators Joanne Chory, the Salk Institute, and Thomas A. Steitz, Yale University, were elected foreign members of the Fellowship of the Royal Society, the world's oldest scientific academy. (9) AAAS Names HHMI Scientists Fellows Nine HHMI investigators, two HHMI international research scholars, and the chair of the K-RITH Scientific Advisory Board were chosen as new fellows of the American Association for the Advancement of Science. The investigators are Frederick W. Alt, Children's Hospital Boston; Jason G. Cyster, University of California, San Francisco; Robert B. Darnell, The Rockefeller University; Gideon Dreyfuss, University of Pennsylvania School of Medicine; Yishi Jin, University of California, San Diego; Jeannie T. Lee, Massachusetts General Hospital; Stuart H. Orkin, Children's Hospital Boston; Li-Huei Tsai, Massachusetts Institute of Technology; and John D. York, Duke University. The international research scholars are Charles M. Boone, University of Toronto, and Freda D. Miller, Hospital for Sick Children, Toronto. The K-RITH board member is Barry R. Bloom, Harvard School of Public Health. |
| Software ID: | |
| Software Version: |